FDA Finds Quality Control Problems At Another Johnson & Johnson Plant
Federal drug inspectors have found problems with yet another Johnson and Johnson drug manufacturing plant, this time located in Lancaster, Pennsylvania.
The drug maker confirmed reports this week that it received a report from the FDA that indicates there are deficiencies at the plant, which is a joint venture between Johnson & Johnson and Merck Consumer Pharmaceuticals. Pepcid is one of the products manufactured at the plant.
The FDA report, known as a Form 483, is not yet available to the public because it contains sensitive industry information that needs to be redacted before it can be released. Neither Johnson and Johnson nor Merck have released any details about the deficiencies found at the plant.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The inspection report comes after Johnson & Johnson has issued a number of recalls as a result of problems with quality control at other plants, particularly through its McNeil Healthcare subsidiary.
On April 30, a recall was announced for nearly 40 liquid children’s medications made by McNeil Consumer Healthcare, including infant Tylenol, Benadryl, and Motrin. The products were recalled due to particulate contamination and irregularities in potency. As a result of the problems, the FDA issued a warning letter about quality control issues at the Johnson & Johnson manufacturing plant in Ft. Washington, Pennsylvania.
The recall affected 136 million bottles of children’s medications, resulting in the shutdown of the plant and the suspension of production of all of McNeil’s children medications. Following that recall, the FDA has received nearly 800 complaints, including at least seven reports of deaths associated with the medication. However, the FDA says its investigations so far have not directly linked any of the recalled products to any of the deaths.
In addition, the company has issued a series of Johnson and Johnson drug recalls for a variety of drugs due to chemical contamination from wood pallets that give the drug a musty smell and have caused a number of people to fall ill. The problem is due to contamination by trace amounts of a chemical called 2,4,6-tribromoanisole, or TBA, which seeped into bottles from wood pallets treated with pesticide. The contaminated drugs had a moldy smell and made some users sick.
Concerned ParentJuly 23, 2010 at 2:27 pm
There is no excuse for these types of issues, especially when it pertains to the health and safety of children. The Executive Management of these facilities should face criminal charges and be sent to jail.
"*" indicates required fields
More Top Stories
Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.
More than 775 Exactech lawsuits have been filed in federal and state courts as parties work toward a plan for bellwether early test trials.
A federal judge has announced he will soon begin remanding 3M earplug lawsuits back to their originating districts for trials over claims of veteran hearing loss.